631 Followers on Owler

Achilles is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer...

Read more

Achilles is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer...

Read more
Achilles CEO: Iraj Ali

CEO

Iraj Ali

CEO Approval Rating

86/100

Annual Revenue
<$1M
Employees
242
Funding
387.2M

Achilles Competitors

1
2
3
4
5
6
7
8
See 8+ competitors

Achilles News

Achilles Press Releases

Achilles Headquarters

245 Hammersmith Road

London, EnglandW6 8PW

44-20-8154-4600

Driving Directions »

Achilles Summary

ABOUT

Overview

Achilles is an England-based biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer. Achilles was founded in 2016. Achilles' headquarters is located in London, England, GB W6 8PW. Achilles' CEO, ...

CEO

Achilles's CEO, Iraj Ali, currently has an approval rating of 86%. Achilles's primary competitors are bluebird, Kite Pharma, NexImmune and 5 more.

Acquisitions

There have been no acquisitions found related to Achilles

Investments

Recent investment data cannot be found related to Achilles

Frequently Asked Questions about Achilles

  1. When was Achilles founded?

    Achilles was founded in 2016
  2. Who is Achilles's CEO?

    Achilles's CEO is Iraj Ali
  3. How much revenue does Achilles generate?

    Achilles generates $ < 1M in revenue
  4. How much funding does Achilles have?

    Achilles has historically raised $387.2M in funding
  1. Where is Achilles's headquarters?

    Achilles's headquarters is in London England, GB
  2. How many employees does Achilles have?

    Achilles has 242 employees
  3. What sector does Achilles operate in?

    Achilles is in Biotechnology, Pharmaceuticals
  4. Who are Achilles's competitors?

    Achilles's top competitors are bluebird, Kite Pharma, NexImmune

Trending Companies